| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Kapadia Sandip serves as a Chief Financial Officer at HRMY and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 9 sells. Those positions are worth an estimated $969K at current prices.
Historically, Kapadia Sandip's trades have earned a strong insider score of 71/100 across 7 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +17.1%.
The biggest single holding is HRMY (~$969K) as Chief Financial Officer. The recent filings there lean toward selling, a net 82,508 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sell | 3,746 | $37.15 | $139,171.39 | -13.3% | - | - | |
| Dec 5, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sale+OE | 20,000 | $39.54 | $790,896.00 | -100% | -28.4% | - | |
| Nov 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sell | 3,427 | $35.00 | $119,945.00 | -100% | +0.2% | - | |
| Aug 15, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sell | 21,573 | $36.50 | $787,377.83 | -100% | -7.0% | - | |
| Apr 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sell | 6,987 | $32.54 | $227,385.94 | -90.4% | -2.5% | -13.8% | |
| Jan 27, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sale+OE | 1,775 | $38.05 | $67,547.27 | -100% | -23.2% | -1.5% | |
| Jan 21, 2025 | HRMY Harmony Biosciences Holdings, Inc. | Chief Financial Officer | Sale+OE | 25,000 | $40.18 | $1,004,597.50 | -100% | -29.6% | -9.3% | |
| Dec 1, 2022 | PASG Passage Bio, Inc. | Director | Sell | 5,000 | $1.19 | $5,964.50 | -100% | +8.4% | -43.9% | |
| Mar 3, 2020 | PASG Passage Bio, Inc. | Director | Buy | 5,000 | $18.00 | $90,000.00 | New | - | - |